QuickView for glycosylceramide metabolic process (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
3. Rectal mucosal biopsies of male and female Ulcerative Colitis patients with 4 weeks remission
4. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
5. L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens

There were no matches for glycosylceramide metabolic process

There were no clinical trials for glycosylceramide metabolic process